NCT06319378 - Cancer Related Major Depression Treated With a Single Dose of Psilocybin
Clinical Trial in Gothenburg, Sweden
The goal of this randomized placebo controlled trial is to compare the antidepressant effect of a single oral dose of psilocybin 25 mg compared to 1 mg in 100 patients with cancer related major depressive disorder. The main question it aims to answer is: The primary objective of this study is to evaluate the efficacy of a single 25 mg oral dose of psilocybin for major depressive disorder (MDD) compared to an activ... Source record lists lead sponsor Section for Affective Disorders; Northern Stockholm Psychiatry and overall status Recruiting.
Last verified: 2026-06-12